Disclosure Panels Details Page

Central Nervous System Cancers Panel - Disclosures as of 12/15/2015

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent Spouse/Domestic Partner/Dependent Potential Conflict Has Attended
Mario Ammirati MD, MBA None None None None None
Joachim Baehring MD Bristol-Myers Squibb Company Forma Therapeutics, Inc None None NA
Marian Birkeland PhD None None None None NA
Henry Brem MD Arbor Pharmaceuticals
Bristol-Myers Squibb Company
Accelerating Combination Therapies
Asclepix Therapeutics
B*Cured: Flighting Brain Cancer
Camden Partners
Galen Robotics
InSightec
LikeMinds, Inc.
Nurami Medical
Perosphere Inc.
StemGen
None None NA -
Paul Brown MD National Cancer Institute Novocure None None None
Jennifer Burns BS None None None None NA
Nicholas Butowski MD AbbVie, Inc.
Amgen Inc.
Bayer HealthCare
Ipsen
Jazz Pharmaceuticals Inc.
Karyopharm Therapeutics
Medicenna
Novartis Pharmaceuticals Corporation
AbbVie, Inc.
Amgen Inc.
Cordance
None None NA -
Marc Chamberlain MD NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas Novartis Advisory Board Nativis
Neonc Inc
None None
Anita Engh PhD None None None None NA
Robert Fenstermaker MD Celgene Corporation
MimiVax
None prIME Oncology MimiVax None -
Fayna Ferkle PharmD None None None None None
Allan Friedman MD None None None None NA -
Kristina Gregory MSN, RN, OCN None None None None NA
Jona Hattangadi-Gluth MD None None None None NA
Matthias Holdhoff MD, PhD None None None None NA
Larry Junck MD None Orbus Pharmaceutical None None NA
Thomas Kaley MD None None None None NA
Jay Loeffler MD Advanced Oncotherapy
Mevion Corporation
None None None NA -
Joan McClure MS None None None None NA
Nicole McMillian MS None None None None NA
Paul Moots MD None None None None NA
Maciej Mrugala MD, PhD, MPH Bristol-Myers Squibb Company
Celldex Therapeutics
ImmunoCellular Therapeutics
Novocure
Novocure
Xcenda
None None None -
Louis Nabors MD University of Pennsylvania None None None NA
Seema Nagpal MD Agios, Inc.
Berg Health LLC
Inovio
Insightec
PharmAbcine
None Biocept
Novocure
Seattle Genetics, Inc.
None NA
Ian Parney MD, PhD Boston Scientific Corporation
Merck & Co., Inc.
AbbVie, Inc. None None NA -
Jana Portnow MD None None None None NA
Donna Powell DHSc, CMD, RT(T) None None None None NA
Lisa Rogers DO None None None None NA -
Nicole Shonka MD None None None None NA -
Dennis Shrieve MD, PhD None None None None NA -
Allen Sills MD None None None None NA -
Lode Swinnen MBChB None Karyopharm Therapeutics None Johns Hopkins University NA
Nam Tran MD, PhD None None None None None -
Christina Tsien MD None Blue Earth Diagnostics Merck & Co., Inc.
Novocure
Tocagen
Varian Medical Systems, Inc.
None NA
Frank Vrionis MD, PhD, MPH Globus
Republic Spine
Florida Board of Medicine
Southeastern Brain Tumor Association
None None None
Stephanie Weiss MD None None None AstraZeneca Pharmaceuticals LP |Regeneron Pharmaceuticals, Inc. NA
Patrick Wen MD None Agios, Inc.
Bayer HealthCare
Boston Pharma
Imvax
Integral Health
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Novocure
Nuvation Bio
None None NA
Nicole Willmarth PhD None None None None NA